NGR-TNF for previously treated advanced malignant pleural mesothelioma [ID655]
Discontinued
Reference number: GID-TA10183
The Department of Health has asked NICE to conduct a Single Technology Appraisal of NGR-TNF for previously treated advanced malignant pleural Mesothelioma.
However, the company have advised that they will not be pursuing a licensing application for NGR-TNF from the European Medicines Authority for this indication at this time. Therefore, NICE has decided to suspend this appraisal on its work programme.
As this appraisal has been referred to NICE we will continue to monitor any development and will update interested parties if the situation changes